SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors weigh an upcoming earnings report against the backdrop of potential U.S. cannabis rescheduling and regulatory shifts. The community remains deeply divided, with some betting on a turnaround fueled by medical growth and policy changes, while others express frustration over leadership, dilution, and long-term performance.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant market volatility driven by a disappointing first-quarter delivery report that missed analyst expectations, fueling intense community debate regarding the company's core automotive demand versus its long-term AI and robotics narrative. While some investors view the stock's weakness as a prime opportunity to buy the dip, others are aggressively betting against the position, citing concerns over declining sales, global competition, and the potential distraction of the anticipated SpaceX IPO.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

Kelly Services is trending due to significant insider and institutional accumulation coupled with an exceptionally low float, fueling community speculation about a potential short squeeze. Investors are closely monitoring upcoming earnings and company conference calls as potential catalysts to ignite further momentum.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is experiencing significant volatility and elevated trading volume as investors aggressively speculate on potential buyout scenarios and M&A activity following unconfirmed media reports. The community is actively debating the company's valuation as a standalone rare-disease franchise versus its appeal as an acquisition target, with many traders closely watching abnormal after-hours trading patterns for signals of a catalyst.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is currently trending as investors speculate on potential contract opportunities and the sector-wide tailwinds expected from an anticipated SpaceX IPO. While retail sentiment remains highly divided between bullish expectations for a short squeeze on the company's small float and bearish skepticism regarding the firm's lack of revenue and recent leadership turnover.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is experiencing heightened volatility as investors weigh aggressive geopolitical escalations in the Middle East and spiking oil prices against persistent market resilience. The community is actively debating whether current price action is a government-led stabilization effort, a classic bull trap, or a sign that the market is beginning to price in further macro instability.

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals is trending following a positive trial update for its prostate cancer candidate, rinzimetostat, combined with a $125 million private placement financing. While some investors are expressing disappointment over the dose optimization results, the community is heavily debating the stock's future potential, with many pointing to its clean safety profile, strong cash position, and heavy institutional backing as signs of a potential long-term recovery.

Vine Hill Capital Investment Corp. is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on May 24, 2024 and is headquartered in Fort Lauderdale, FL.

CoinShares Plc.

CoinShares is capturing attention following its Nasdaq listing, with the community analyzing the firm's valuation gap compared to U.S. competitors and debating the impact of post-SPAC volatility. Investors are currently weighing the company's profitability and dividend potential against broader crypto market sentiment and geopolitical pressures affecting the sector.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing intense market activity as it joins the S&P 500 index, triggering mandatory buying from index funds and ETFs alongside continued speculative interest linked to AI infrastructure investments. The community is sharply divided, with bulls pointing to the company's critical role in the photonics supply chain and recent hyperscaler backing, while bears argue the valuation has reached unsustainable levels and is primed for a significant correction.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently under intense community scrutiny following a major exploit on the Drift Protocol, fueling debates about network security and institutional trust. While some investors are accumulating on dips based on developer momentum, others are concerned about market volatility and the long-term impact of regulatory pressures on the broader ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Royal Orchid Hotels signs 43-Key property in Udaipur

The property will be operated under a hotel management agreement as part of the company’s asset-light expansion strategy

Royal Orchid Hotels Deepens Vadodara Footprint with Launch of Regenta Z

Royal Orchid Hotels Limited ( ($IN:ROHLTD) ) has issued an announcement. Royal Orchid Hotels Ltd. has launched Regenta Z Vadodara, its fourth prope...

Sustained tourism, corporate travel to push room rates up to 6% in 2026

Amid fast-paced growth momentum in India’s hospitality industry, hotel room rates are expected to rise up to six per cent to be in the range of ₹9,400 to ₹9,700 in 2026, driven by continued growth in domestic tourism, corporate travel, and demand continuing to outpace supply across most markets in the country. In 2025, hotel room rates rose by seven per cent compared with 2024, according to Hotelivate, a hotel consulting firm. While December was expected to carry this momentum forward, operational disruptions at IndiGo towards the end of the year are likely to temper performance in the final month. Consequently, the industry is now projected to close CY2025 with occupancy levels in the range of 65 to 67 per cent and ARRs between ₹8,800 and ₹9,200, as per data shared by HVS Anarock. This comes after hotel room rates hit record highs in 2024, and 2025 saw several events affecting growth, from geopolitical issues to an aeroplane crash, extended rains and flight disruptions. However, the hospitality industry’s room rate growth is now expected to moderate over time or enter a phase of stabilisation marked by measured and sustainable growth across key operating metrics, according to industry experts.

Royal Orchid Hotels Expands in Goa with New Property Launch

Royal Orchid Hotels Limited ( ($IN:ROHLTD) ) has shared an update. Royal Orchid Hotels Ltd. has announced the opening of its new property, Regenta ...

Brief India: Axis PUNCH: Garware Hi-Tech Films Ltd - 24th October, 2025 and more

In this briefing: Axis PUNCH: Garware Hi-Tech Films Ltd - 24th October, 2025 Hindustan Unilever Ltd - GST Transition Led to Short-Term Impact; Maintain HOLD Colgate Palmolive (India) Ltd - Miss on All Fronts; Gradual Recovery Ahead Can Fin Homes - Strong on Profitability, Weak on Growth Primer: Royal Orchid Hotels (ROHL IN) - Oct 2025 1. Axis PUNCH: Garware Hi-Tech Films Ltd - 24th October, 2025 Growth Beyond the Near-term Headwinds: GHFL’s Q1FY26 performance was impacted by adverse weather conditions in the domestic market and macro uncertainties in the global market. While the company expects a flattish performance in FY26, the growth prospects remain strong with the company adding capacities in FY26 and FY27. The newer capacities are expected to drive the next phase of growth, reaching full utilization within 2-3 years of commissioning. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Royal Orchid Hotels Ltd. engages in the business of operating and managing hotels and resorts. It operates under the India and Outside India geographical segments. The company was founded by Chander Kamal Baljee in 1973 and is headquartered in Bangalore, India.

Current Price	310.10
Prev Close	301.20
Open	300.50
Dividend Yield	0.64%
50-Day Moving Average	346.99
Beta	-0.12
Avg. Volume	77,828.47
PE Ratio	22.98

52-Week High	593.40
52-Week Low	269.40
Market Capitalization	8.38B
EPS (Annual)	17.23
Price to Book	3.44
Revenue Per Employee	3.4M

ROHLTD.NSE
Royal Orchid Hotels Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest ROHLTD.NSE News

ROHLTD.NSERoyal Orchid Hotels Ltd.